Biobanking of human pluripotent stem cells in China-Reference-Cited by-同舟云学术

Biobanking of human pluripotent stem cells in China

Published:2022-06-02 Issue:7 Volume:55 Page:
ISSN:0960-7722
Container-title:Cell Proliferation
language:en
Short-container-title:Cell Proliferation

Author:

Stacey Glyn Nigel¹²³^ORCID,Hao Jie¹²^ORCID

Affiliation:

1. National Stem Cell Resource Centre Institute of Zoology Chinese Academy of Sciences Beijing China

2. Innovation Academy for Stem Cell and Regeneration Chinese Academy of Sciences Beijing China

3. International Stem Cell Banking Initiative Barley UK

Publisher

Wiley

Subject

Cell Biology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cpr.13180

Reference20 articles.

1. Health and Family Planning Commission (HFPC now the National Health Commission) and the Chinese Food and Drug Administration (CFDA).Guidelines for quality control and preclinical research stem cell agent (Trial).2015. [干细胞制剂质量控制及临床前研究指导原则 (试行)]

2. Health and Family Planning Commission (HFPC now the National Health Commission) and the Chinese Food and Drug Administration (CFDA).Administrative Measures for Stem Cell Clinical Research (Trial).2015. [干细胞临床研究管理办法]

3. Chinese Food and Drug Administration (CFDA).Guideline for research and evaluation of cell therapy products (Trial).2017. 《细胞治疗产品研究与评价技术指导原则 (试行) 》

4. Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI)

5. Consensus Guidance for Banking and Supply of Human Embryonic Stem Cell Lines for Research Purposes

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Innovations in bio-engineering and cell-based approaches to address immunological challenges in islet transplantation;Frontiers in Immunology;2024-04-08

2. Mesenchymal stromal cell biotherapy for Parkinson’s disease premotor symptoms;Chinese Neurosurgical Journal;2023-10-13